Dolby Laboratories Inc (NYSE: DLB) has reported earnings for its fourth fiscal quarter (ending September 30) of $0.10 versus $0.29 for the same period a year ago — a decline of -66%. This performance was $-0.43 short of the consensus estimate of $0.53. For the latest four quarters through September 30, E.P.S. were $2.10 compared to $1.84 a year ago — an increase of 14%.
Recent Price Action
Dolby Laboratories Inc (NYSE: DLB) stock closed at $87.77 on 11/16/23 after a decline of -1.0%. Relative to the market the stock has been strong over the last nine months and has risen 2.2% during the last week.
Current PriceTarget Research Rating
DLB is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Dolby Laboratories has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Dolby Laboratories has a very low Appreciation Score of 12 but a slightly positive Power Rating of 62, resulting in the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment